Robust growth is expected for sales of minimally invasive surgical products through 2020. The market, which was valued at $8.4 billion in 2014 and includes arthroscopes, bronchoscopes, endoscopes, instrumentation, access devices, and related products is benefiting from the adoption of new devices and techniques that expand the range of surgical caseloads; patient and clinical preference for less-invasive surgical methods; and rising access to advanced technologies in emerging markets. This analysis-which provides detailed forecasts for product segments, clinical caseloads, and global regions-explores the key forces shaping the market, examines competitive market shares, and provides detailed quantitative segmentation for endoscopic procedures and devices.
Critical Issues Covered in this Report:
• The competitive landscape for these devices in the U.S. and international markets;
• Quantitative factors including revenues, procedures, and product sales; and
• Surgical volumes, caseloads, and other key infrastructure and market metrics.
© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy
